Personalis and Tempus broaden their collaboration with the biopharmaceutical sector By Investing.com
Expanded collaboration to allow higher biopharmaceutical entry to Personalis (NASDAQ:) MRD resolution…
Novo Nordisk invests $1.2 billion in new Danish manufacturing unit to broaden past insulin and weight reduction
The 430,000 sq. foot manufacturing facility in Odense is modular, permitting Novo…
The occupying Zionist entity to increase settlements in Golan Heights after Assad’s fall
The The occupying Zionist entityi authorities has authorised a plan to encourage…
